NorthRock Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,046
| Closed | -$275K | – | 325 |
|
|
2022
Q1 | $275K | Sell |
5,046
-1,116
| -18% | -$60.8K | 0.02% | 255 |
|
|
2021
Q4 | $340K | Buy |
+6,162
| New | +$340K | 0.03% | 221 |
|
|
2021
Q3 | – | Sell |
-4,031
| Closed | -$201K | – | 282 |
|
|
2021
Q2 | $201K | Buy |
+4,031
| New | +$201K | 0.02% | 243 |
|
|
2020
Q1 | – | Sell |
-13,382
| Closed | -$786K | – | 239 |
|
|
2019
Q4 | $786K | Buy |
+13,382
| New | +$786K | 0.08% | 117 |
|
|
2019
Q2 | – | Sell |
-4,101
| Closed | -$217K | – | 84 |
|
|
2019
Q1 | $217K | Buy |
+4,101
| New | +$217K | 0.06% | 79 |
|